Location: Greenwich, CT
CIK: 0001596452 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 8, 2022
Total Value: $233M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XBI | SPDR S&P Biotech ETF | 100,000 | $11.2M | 4.8% | $111.96 | — | Cash Securities | 78464A870 |
| UNH | UnitedHealth Group Inc | 17,500 | $8.787M | 3.8% | $353.54 | +19.4% | Cash Securities | 91324P102 |
| MCK | McKesson Corp | 35,000 | $8.7M | 3.7% | $159.43 | +34.7% | Cash Securities | 58155Q103 |
| TMO | Thermo Fisher Scientific Inc | 12,500 | $8.341M | 3.6% | $542.36 | +13.8% | Cash Securities | 883556102 |
| DHR | Danaher Corp | 25,000 | $8.225M | 3.5% | $115.08 | +134.7% | Cash Securities | 235851102 |
| HUM | Humana Inc | 17,500 | $8.118M | 3.5% | $349.97 | +21.4% | Cash Securities | 444859102 |
| ELV | Anthem Inc | 17,500 | $8.112M | 3.5% | $397.15 | 0.0% | Cash Securities | 036752103 |
| UHS | Universal Health Services Inc | 60,000 | $7.78M | 3.3% | $125.78 | 0.0% | Cash Securities | 913903100 |
| LLY | Eli Lilly & Co | 27,500 | $7.596M | 3.3% | $191.90 | +27.1% | Cash Securities | 532457108 |
| AVTR | Avantor Inc | 180,000 | $7.585M | 3.2% | $20.57 | +91.6% | Cash Securities | 05352A100 |
| THC | Tenet Healthcare Corp | 90,000 | $7.352M | 3.2% | $39.24 | +86.2% | Cash Securities | 88033G407 |
| — | Laboratory Corp of America Ho | 22,500 | $7.07M | 3.0% | $166.12 | — | Cash Securities | 50540R409 |
| ABT | Abbott Laboratories | 50,000 | $7.037M | 3.0% | $89.30 | +32.9% | Cash Securities | 002824100 |
| COR | AmerisourceBergen Corp | 52,500 | $6.977M | 3.0% | $100.16 | +16.9% | Cash Securities | 03073E105 |
| HCA | HCA Healthcare Inc | 26,987 | $6.934M | 3.0% | $172.44 | +36.9% | Cash Securities | 40412C101 |
| BSX | Boston Scientific Corp | 160,000 | $6.797M | 2.9% | $38.96 | +7.9% | Cash Securities | 101137107 |
| BAX | Baxter International Inc | 75,000 | $6.438M | 2.8% | $73.64 | -0.6% | Cash Securities | 071813109 |
| PFE | Pfizer Inc | 100,000 | $5.905M | 2.5% | $40.23 | 0.0% | Cash Securities | 717081103 |
| CRL | Charles River Laboratories In | 15,000 | $5.652M | 2.4% | $227.21 | +71.0% | Cash Securities | 159864107 |
| ABBV | AbbVie Inc | 40,000 | $5.416M | 2.3% | $101.71 | 0.0% | Cash Securities | 00287Y109 |
| GMED | Globus Medical Inc | 75,000 | $5.415M | 2.3% | $70.47 | +3.0% | Cash Securities | 379577208 |
| ZBH | Zimmer Biomet Holdings Inc | 42,500 | $5.399M | 2.3% | $126.23 | 0.0% | Cash Securities | 98956P102 |
| CVS | CVS Health Corp | 50,000 | $5.158M | 2.2% | $80.49 | 0.0% | Cash Securities | 126650100 |
| JNJ | Johnson & Johnson | 30,000 | $5.132M | 2.2% | $136.48 | +6.3% | Cash Securities | 478160104 |
| BDX | Becton Dickinson and Co | 17,500 | $4.401M | 1.9% | $228.04 | -2.0% | Cash Securities | 075887109 |
| BMY | Bristol-Myers Squibb Co | 70,000 | $4.365M | 1.9% | $49.23 | 0.0% | Cash Securities | 110122108 |
| IQV | IQVIA Holdings Inc | 15,000 | $4.232M | 1.8% | $160.64 | +61.5% | Cash Securities | 46266C105 |
| MOH | Molina Healthcare Inc | 12,500 | $3.976M | 1.7% | $187.70 | +58.4% | Cash Securities | 60855R100 |
| OPCH | Option Care Health Inc | 130,000 | $3.697M | 1.6% | $23.20 | +13.2% | Cash Securities | 68404L201 |
| ISRG | Intuitive Surgical Inc | 10,199 | $3.665M | 1.6% | $344.06 | 0.0% | Cash Securities | 46120E602 |
| BMRN | BioMarin Pharmaceutical Inc | 40,000 | $3.534M | 1.5% | $82.83 | -0.4% | Cash Securities | 09061G101 |
| WST | West Pharmaceutical Services | 7,500 | $3.518M | 1.5% | $425.92 | 0.0% | Cash Securities | 955306105 |
| SYK | Stryker Corp | 12,500 | $3.343M | 1.4% | $181.42 | +38.4% | Cash Securities | 863667101 |
| CYH | Community Health Systems Inc | 249,768 | $3.324M | 1.4% | $13.04 | -3.7% | Cash Securities | 203668108 |
| CAH | Cardinal Health Inc | 60,000 | $3.089M | 1.3% | $44.62 | 0.0% | Cash Securities | 14149Y108 |
| HOLX | Hologic Inc | 40,000 | $3.062M | 1.3% | $68.21 | +7.8% | Cash Securities | 436440101 |
| SEM | Select Medical Holdings Corp | 90,000 | $2.646M | 1.1% | $18.57 | -14.6% | Cash Securities | 81619Q105 |
| GH | Guardant Health Inc | 25,000 | $2.501M | 1.1% | $103.43 | 0.0% | Cash Securities | 40131M109 |
| NTRA | Natera Inc | 25,000 | $2.335M | 1.0% | $103.78 | 0.0% | Cash Securities | 632307104 |
| SRPT | Sarepta Therapeutics Inc | 25,000 | $2.251M | 1.0% | $85.49 | 0.0% | Cash Securities | 803607100 |
| EHC | Encompass Health Corp | 30,000 | $1.958M | 0.8% | $56.54 | -12.6% | Cash Securities | 29261A100 |
| EW | Edwards Lifesciences Corp | 15,068 | $1.952M | 0.8% | $116.64 | 0.0% | Cash Securities | 28176E108 |
| CRSP | CRISPR Therapeutics AG | 25,000 | $1.895M | 0.8% | $87.36 | 0.0% | Cash Securities | H17182108 |
| — | Mirati Therapeutics Inc | 9,918 | $1.455M | 0.6% | $146.70 | — | Cash Securities | 60468T105 |
| — | Blueprint Medicines Corp | 10,000 | $1.071M | 0.5% | $107.10 | — | Cash Securities | 09627Y109 |